These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3266475)

  • 21. Biologically active analogs of thymopentin with enhanced enzymatic stability.
    Heavner GA; Kroon DJ; Audhya T; Goldstein G
    Peptides; 1986; 7(6):1015-9. PubMed ID: 3031628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoregulation by thymopoietin.
    Goldstein G; Lau CY
    J Supramol Struct; 1980; 14(3):397-403. PubMed ID: 6971374
    [No Abstract]   [Full Text] [Related]  

  • 23. Synthesis of deacetyl-thymosin beta 12 and examination of its immunological effects on the impaired T and B lymphocytes in uremic patients.
    Abiko T; Sekino H
    Biotechnol Ther; 1993; 4(3-4):221-37. PubMed ID: 8292971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and immunological effect of thymic humoral factor-gamma-2 analogues.
    Abiko T; Ogawa R
    Prep Biochem Biotechnol; 2002 May; 32(2):117-25. PubMed ID: 12071642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infantile thymectomy: alterations in circulating T-cell subpopulations and in vitro effects of thymopoietin pentapeptide.
    Gupta S; Kapoor N; Goldstein G; Good RA
    Clin Immunol Immunopathol; 1979 Apr; 12(4):404-9. PubMed ID: 313293
    [No Abstract]   [Full Text] [Related]  

  • 26. [Advances in structure and function of thymic polypeptide hormone].
    Yao ZJ; Shen BF
    Sheng Li Ke Xue Jin Zhan; 1985 Jan; 16(1):52-6. PubMed ID: 3890172
    [No Abstract]   [Full Text] [Related]  

  • 27. Immuno-regulating peptides, I. Synthesis and structure-activity relationships of thymopentin analogs.
    Kisfaludy L; Nyéki O; Schön I; Dénes L; Ember J; Szporny L; Hajós G; Szende B
    Hoppe Seylers Z Physiol Chem; 1983 Aug; 364(8):933-40. PubMed ID: 6629331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of thymosin alpha1 fragments on T-lymphocyte transformation in the uremic state.
    Abiko T; Sekino H; Higuchi H
    Chem Pharm Bull (Tokyo); 1980 Nov; 28(11):3411-5. PubMed ID: 6971182
    [No Abstract]   [Full Text] [Related]  

  • 29. In vitro differentiation of two surface markers for immature T cells by the synthetic pentapeptide, thymopoietin.
    Nash L; Good RA; Hatzfeld A; Goldstein G; Incefy GS
    J Immunol; 1981 Jan; 126(1):150-3. PubMed ID: 6969740
    [No Abstract]   [Full Text] [Related]  

  • 30. Thymopoietin enhances the allogeneic response and cyclic GMP levels of mouse peripheral, thymus-derived lymphocytes.
    Sunshine GH; Basch RS; Coffey RG; Cohen KW; Goldstein G; Hadden JW
    J Immunol; 1978 May; 120(5):1594-9. PubMed ID: 207773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunological status of patients with recurrent herpes simplex infections. In vitro effect of thymopoietin and splenin-derived and partially modified peptides on peripheral blood lymphocytes in comparison to a thymus extract].
    Simon HU; Roth H; Forner K; Haroske D
    Allerg Immunol (Leipz); 1990; 36(2):111-8. PubMed ID: 1975471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The in vitro effect of the thymic factor thymopoietin on a subpopulation of lymphocytes from severely malnourished children.
    Jackson TM; Zaman SN
    Clin Exp Immunol; 1980 Mar; 39(3):717-21. PubMed ID: 6769624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Syntheses and effects of a thymopoietin II fragment and its analogs on the impaired T-cell transformation in a patient with common variable immunodeficiency.
    Abiko T; Shishido H; Sekino H
    J Appl Biochem; 1985 Dec; 7(6):408-22. PubMed ID: 3879489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subpopulations of human T lymphocytes. II. Effect of thymopoietin, corticosteroids, and irradiation.
    Gupta S; Good RA
    Cell Immunol; 1977 Nov; 34(1):10-8. PubMed ID: 303151
    [No Abstract]   [Full Text] [Related]  

  • 35. Improvement of natural killer activity and of T cells after thymopoietin pentapeptide therapy in a patient with severe combined immunodeficiency.
    Fiorilli M; Sirianni MC; Pandolfi F; Quinti I; Tosti U; Aiuti F; Goldstein G
    Clin Exp Immunol; 1981 Aug; 45(2):344-51. PubMed ID: 7032772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural requirements for the biological activity of thymopentin analogs.
    Heavner GA; Audhya T; Kroon D; Goldstein G
    Arch Biochem Biophys; 1985 Oct; 242(1):248-55. PubMed ID: 2996431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Structural similarity and functional activity of molecular fragments of staphylococcal enterotoxin B and thymopoietin II].
    Vegner RE; Rituma IR; Chipens GI; Duplishcheva AP; Mysiakin EB
    Bioorg Khim; 1987 Jan; 13(1):122-4. PubMed ID: 3566816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thymopoietin-like substance in human skin.
    Chu AC; Goldstein G; Patterson J; Berger C; Takezaki S; Edelson R
    Lancet; 1982 Oct; 2(8301):766-7. PubMed ID: 6125832
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunohistochemical localization of thymopoietin with an antiserum to synthetic Cys-thymopoietin28-39.
    Viamontes GI; Audhya T; Goldstein G
    Cell Immunol; 1986 Jul; 100(2):305-13. PubMed ID: 2428508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response to thymopoietin pentapeptide in patient with DiGeorge syndrome.
    Aiuti F; Businco L; Rossi P; Quinti I
    Lancet; 1980 Jan; 1(8159):91. PubMed ID: 6101433
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.